<i>α</i>‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease
Masanori Tokoro(Oita University), Hirotaka Shibata(Oita University), Kazunari Murakami(Oita University), Takayuki Masaki(Oita University), Koro Gotoh(Oita University), Masataka Seike(Oita University), Koichi Honda(Yamagata University), Masao Iwao, Yuka Hirashita(Oita University), Yoko Kudo(Chiba University), Mizuki Endo(Oita University), Mie Arakawa(Oita University), Tetsuya Kakuma(Oita University), Junya Oribe(Oita University)
Cited by 14
Related Papers
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment
|Digestive Endoscopy|2013|469
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants
|Digestive Endoscopy|2018|261
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
|Journal of Gastroenterology|2018|242